Metronidazole [Flagyl; 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole] and other derivatives of nitroimidazole are used extensively to treat infections due to anaerobic protozoa and bacteria (13) . The main properties of these compounds that account for their therapeutic success are their selective uptake by and cytotoxic action on anaerobic organisms (9-11, 15, 29, 39) . Their toxicity for aerobic microorganisms and for mammals is low (8, 10, 11, 40) . However, recent studies have demonstrated that these drugs induce mutations in bacteria resistant to their killing activity (18, 19, 25, 32, 35, 42) .
The mechanism of the cytotoxic and mutagenic action of nitroimidazoles on microorganisms is not well understood. It is assumed that derivatives arising by the reduction of the nitro group are responsible for the observed activities (4, 9, 15, 30) . The products of reduction are not known but are assumed to be highly reactive and toxic for microorganisms, possibly by binding to deoxyribonucleic acid and other biopolymers (15, 43) . In anaerobes, extensive transformation decreases the intracellular concentration of the unchanged drug and thus creates a gradient driving the uptake (15, 29) .
The specificity of nitroimidazoles may be due to the occurrence of different redox processes in anaerobes and aerobes. In anaerobes low-redox potential reactions involving ferredoxin-or flavodoxin-type electron transport proteins are important (28) . Such reactions are either nonexistent or, at best, insignificant in the metabolism of aerobes. It has been suggested that ferredoxin mediates the reduction of the nitro group of nitroimidazoles in susceptible anaerobes (4, 9, 15, 30) .
In this paper we demonstrate a parallelism in the action of 12 (6) , pH 6.0, with 10% heat-inactivated horse serum, and T. foetus was cultured in the same medium without agar, pH 7.3, with 10% calf serum. The S. typhimurium strains were grown in Columbia broth (Baltimore Biological Laboratories, Cockeysville, Md.). All cultures were incubated at 37°C.
Growth inhibition tests. In most experiments, a single-layer agar plate technique was used (33) . For the two trichomonad species, 0.1 ml of a 24-h culture of the test organism was mixed with 12 ml of plate medium (TYM medium of appropriate pH containing 0.8% agar and 10% serum) and poured into a petri dish of 100-mm diameter. Aqueous solutions (up to 500 ,lg/ml) of the compounds to be tested were added in a 20-,pI volume to 6.35-mm sterile filterpaper disks (no. 1599-33, Difco Laboratories, Detroit, Mich.). The disks were placed on the plates, which were incubated for 48 h at 37°C in anaerobic jars (GasPak anaerobic system; BBL) containing an H2 and CO2 atmosphere (generated by GasPak no. 70304 disposable gas generator envelopes). The diameter of the clear zone around the disks was measured to the nearest millimeter.
The action of metronidazole was also tested in liquid cultures to obtain absolute values of its minimum inhibitory concentration for the microorganisms used in this study. Metronidazole was added to the media (TYM for trichomonads and Columbia broth for S. typhimurium) at concentrations ranging from 0.1 to 500 ug/ml for trichomonads and from 10 to 500 ,ug/ml for S. typhimurium. Tubes with trichomonads were incubated under the conditions used for the plates. Tubes with S. typhimurium were incubated both aerobically and anaerobically. After 48 h the minimum inhibitory concentration was recorded as the lowest concentration yielding no visible growth. Certain compounds that were not inhibitory in the plate assay were also tested in liquid cultures of T. foetus in concentrations ranging from 0.1 to 250 ,ug/ml to determine whether lack of effect was due to slow diffusion of the compounds in the agar.
Mutagenicity tests. Assays using S. typhimurium TA 100 and TA 100 FR1 were carried out according to the method of Ames and co-workers (1) by incorporating the bacterium and the tested compound into an agar overlay. The plates were incubated at 37°C for 46 h aerobically or for 16 h in an anaerobic jar followed by 30 h of aerobic incubation (32) . Revertants to histidine independence were enumerated after incubation. Trichomonad homogenates. T. foetus and T. vaginalis cells were harvested from mass cultures (about 1,000 ml) by centrifugation, washed in 250 mM sucrose, resuspended in deaerated 250 mM sucrose containing 1 mM mercaptoethanol, and homogenized with a Teflon tissue homogenizer. The homogenization was performed, and the homogenate was kept under anaerobic conditions. Details of these procedures were published earlier (20) .
Spectrophotometric tests. All solutions used were degased by boiling or by flushing with argon and were subsequently kept under this gas. The necessary amount of buffer or diluted homogenate was placed in semimicro spectrophotometric cells with stoppers (0.7-ml volume, 5-mm optical path; type 29, Precision Cells, Inc., Hicksville, N.Y.) that were closed with soft sleeve-type rubber stoppers (5 by 9 mm; no. 8826, A.M. Thomas Co., Philadelphia, Pa.) and were flushed with argon, using 26-gauge hypodermic needles as gas inlet and vent. Additions were made through the stopper with microliter syringes (Hamilton Co., Reno, Nev.). Changes in absorbance were followed at 25°C in a recording spectrophotometer. The following molar absorbance values (M-1 cm-l) were used: ferredoxin (reduced minus oxidized) E390, 17,300 (21); methyl viologen (reduced) em, 6 ,300 (20) ; metronidazole (no. 8) E320, 9,310 (43) .
Compounds tested. The nitroimidazole derivatives used in this work are listed in Table 1 Table 1 summaIzes our results obtained with 12 nitroimidazole derivatives. Inhibitory activity on trichomonads and mutagenic activity in the S. typhimurium test are expressed as relative values; effectiveness of metronidazole (no. 8) used is expressed as 100%. Comparison was done on a weight basis. Any compound with an activity of less than 1% of metronidazole is regarded as inactive. The results show that both trichomonads were strongly inhibited by metronidazole but that there were marked differences in the activity of the other compounds. There was a definite mutagenicity in S. typhimurium TA 100, both under aerobic and anaerobic conditions, and in TA 100 FR, under anaerobiosis for metronidazole and some of the other compounds. None of the compounds induced mutations in TA 100 FR1 under aerobic conditions. Metronidazole, used in concentrations up to 500 ,ug/ml, did not affect either aerobic or anaerobic growth of either S. typhimurium strain.
RESULTS
The results also indicate that for any given compound the effects on different biological systems, i.e., killing of two eukaryotic anaerobic In an anaerobic chemical system, metronidazole (no. 8) and its 4-nitro analogue (no. 3) are able to oxidize methyl viologen or ferredoxin that had been reduced with dithionite (Fig. 1) As described earlier (20) , homogenates of trichomonads transfer electrons from pyruvate to ferredoxin or methyl viologen in a reaction catalyzed by an anaerobic pyruvate dehydrogenase (pyruvate synthase). This reaction can be followed spectrophotometrically (Fig. 2) . If metronidazole is added to this system, the reaction proceeds at the same ratio as in the absence of the drug after a brief delay period. The duration of this delay is proportional to the amount of metronidazole added. The results suggest that metronidazole does not inhibit the dehydrogenase activity but serves rather as an electron acceptor, thus keeping the methyl viologen oxidized. From the rate of the dehydrogenase reaction, length of delay, and amount of drug added, it can be calculated that four reducing equivalents were accepted by the drug.
All compounds studied were also tested in the pyruvate dehydrogenase assay (Table 1) . With the exception of compounds 4 and 5, all interfered in the same way and to the same extent with the reduction of methyl viologen, indicating reduction ofthe compound in this system. The reduction of metronidazole can be followed directly by the decrease in its absorbance at 320 nm. Homogenates of T. foetus are able to perform this reaction under anaerobic conditions if pyruvate is used as substrate (Fig. 3) . The specific activity observed in the absence of exogenous electron transfer compounds was 47 nmol of nitroimidazole reduced/min per ug of protein. This value was markedly increased by the addition of ferredoxin from C. pasteurianum (120 nmol/min per ,g of protein) or of methyl viologen (150 nmol/min per ,ug of protein). The latter values are close to those ob- Clearly the activity observed in a given assay system depends not only on the compound tested, but also on the assay used. Thus, the use of other strains of organisms or other methods would likely give different results. Therefore, we wish to emphasize the overall results and not the relatively small numerical differences among the different drugs tested. Nevertheless, data obtained with the different compounds are usually in agreement with published results.
As expected, all nitroimidazoles currently used in human or veterinary medicine, as well as 1-methyl-5-nitroimidazole (no. 6), are highly active against trichomonads with minimum inhibitory concentration values below 1 jig/ml.
The inactivity of the 4-nitro analogue of metronidazole (no. 3) is in agreement both with the findings of Kajfez et al. (16) and with the general conclusion that the 5-nitro compound is the more active of any pair of4-nitro and 5-nitro derivatives (5, 17) . Of interest is the observation that the major metabolic derivatives of metronidazole (no. 9 and 10) that have been demonstrated in the urine of humans and rodents (36) are less active than the parent compound, in agreement with published data (16, 31) . Methyl substitution on both nitrogens (no. 4 and 5) abolishes the activity.
Metronidazole and several other compounds tested at very high concentrations did not inhibit growth of S. typhimurium under aerobic or anaerobic conditions. This confirms reports of the resistance by different Enterobacteriaceae to nitroimidazole derivatives (10, 11) . All compounds active against trichomonads were found, however, to be mutagenic in the S. typhimurium tests. The mutagenicity of several nitroimidazoles has been reported (18, 19, 25, 32, 35, 42) . As confirmed in this paper, all these compounds are weak mutagens, producing about one revertant or less per nanomole of compound in the S. typhimurium test (25) . Similar results were obtained for several compounds in the aerobic TA 100 test (H. S. Rosenkranz, W. T. Speck, and J. E. Stambaugh, Jr., Mutat. Res., in press). We found the two major urinary metabolites (no. 9 and 10) of metronidazole less mutagenic than the parent compound, showing a parallelism to the antitrichomonad activities. On this basis, the urine of patients treated with metronidazole is expected to be mutagenic (35) , but less so than the drug itself. Other workers, using another strain (TA 1535), reported, however, that the urine was more mutagenic and attributed this finding to the metabolic activation ofmetronidazole in the whole organism (18, 19) . The presence in urine of compound 9, an oxidative metabolite of metronidazole, was assumed to be responsible for this effect. On TA 1535 this compound is indeed more active than metronidazole (19) . The contradiction with our findings can be resolved if all data are converted to absolute values. Although compound 9 induces the same number of revertants in TA 100 and TA 1535, metronidazole is much less active in TA 1535 than in TA 100. The reason for this strain difference is not clear, but it seems that the effect is due to a low susceptibility of TA 1535 to metronidazole.
It has been repeatedly suggested that the reduction of the nitro group is an essential step in the antimicrobial action of nitroimidazole derivatives on anaerobes (4, 9, 15, 30) . Our results suggest that reduction of the nitro group is also necessary for their mutagenic activity. The employed tester strain TA 100 has an active aerobic nitroreductase (23) , as do most strains of S. typhimurium. Thus it is conceivable, as has been suggested previously (24, 32) , that this enzyme converts nitro compounds into active reduced derivatives. The nitroreductasedeficient tester strain TA 100-FR1, when exposed to nitroimidazoles, gives no revertants under aerobic conditions, extending the results of a previous report (32) . Under anaerobic conditions, however, the same strain gives revertants when exposed to the same compounds, suggesting that TA 100-FR1 has other reducing systems capable of activating nitroimidazoles in the absence of oxygen. Ferredoxin has been found in anaerobically grown Escherichia coli (41) , and thus its occurrence in S. typhimurium seems to be likely. These findings suggest that the mutagenic action of nitroimidazoles is also due to certain reduced metabolites.
With the exception of those carrying methyl groups on both nitrogens, all compounds tested were reduced to the same extent and with similar kinetics in an in vitro enzymatic assay system. Thus, all active compounds are reducible, supporting the idea that reductive biotransformation is an essential component of the mechanism of action. Since the reducible compounds show different levels of activity, other properties of the molecules must also play a major role, possibly determining the interaction ofthe reduced products with cell components.
It is generally assumed that the reduction of nitroimidazoles is mediated by a ferredoxin-or flavodoxin-type electron transport protein (4, 9, 15, 30) . In these studies, we found that metronidazole can be reduced in a non-enzymatic reaction by chemically reduced ferredoxin or methyl viologen, as shown by the oxidation of these electron donors.
These data are compatible with theoretical considerations. The possibility of a redox reac- tion between ferredoxin and nitroimidazole derivatives has been postulated on the basis ofthe redox potentials of the reactants (9, 15, 30) . Because their reduction is irreversible, nitroimidazoles do not form redox couples, so polarographic data have to be used to characterize their reducibility. It has been shown that at pH 7 most 5-nitroimidazole derivatives have a halfwave potential (E112) of about -450 mV and that the 4-nitro analogue of metronidazole has an E112 of about -550 mV (7, 30, 34 (20, 22) . Accordingly, these acceptors are first reduced by the substrates in enzymatic reactions and then in turn reduce the nitroimidazoles in non-enzymatic reactions.
An easy way to test nitroimidazole reduction in biological systems, a method used for all compounds, is to see whether any of the compounds interferes with the anaerobic pyruvate dehydrogenase assay. As long as reducible nitroimidazoles are present, they will act as terminal electron acceptors and will keep the methyl viologen reduced, i.e., colorless.
The number of electrons transferred to metronidazole during in vitro reduction was determined in several experimental systems, including experiments with ferredoxin, the assumed natural electron donor, reduced by dithionite or by anaerobic cell homogenates. The calculated number was four in all cases, which is in agreement with results obtained on C. pasteurianum homogenates (G. Coombs, personal communication). However, these results are at variance with a published work using different methods suggesting a six-electron transfer (30) . These experiments utilized purified C. pasteurianum hydrogenase supplied with benzyl viologen or crude extracts of C. acetobutilicum supplemented with pyruvate and methyl viologen and measured H2 uptake or decrease in H2 production, respectively (30) . The reason for this difference is not clear. A four-electron reduction is observed in the chemical titration of metronidazole where about 2 mol of dithionite are oxidized by 1 mol of drug and dithionite in excess remains unchanged (9, 43; M. Tomasz, personal communication). Direct current polarographic measurements at pH values below 10.0 show a complex wave pattern, in which the first wave corresponds to a four-electron reaction (7) . Alternating current polarography at pH 6.0 also gives a current height corresponding to the same degree of reduction, as determined by the use ofmodel compounds (Y. W. Chien, personal communication). These results suggest that the major reduction products correspond to the reduction level of a hydroxylamine derivative. Since these products have not been isolated, their chemical nature remains conjecture. It seems reasonably certain, however, that in ferredoxin-mediated reactions no further reduction occurs. The fact that both dithionite and reduced methyl viologen transfer the same number of electrons as does ferredoxin suggests that these compounds may be used in model experiments, which can contribute to understanding the mechanism of action of nitroimidazoles on susceptible anaerobes. Since the interaction of nitroimidazoles with nitroreductases ofunsusceptible bacteria and the products of this interaction have not been studied, the significance of the above results in understanding the mutagenic action remains to be elucidated.
